Target and reality of adjuvant endocrine therapy in postmenopausal patients with invasive breast cancer

Previous research evaluating the use of adjuvant endocrine therapy among postmenopausal breast cancer patients showed with 15–50% wide ranges of non-adherence rates. We evaluated this issue by analysing an unselected study group comprising of 325 postmenopausal women, diagnosed from 1997 to 2003 wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Güth, U, Huang, D J, Schötzau, A, Zanetti-Dällenbach, R, Holzgreve, W, Bitzer, J, Wight, E
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2008
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2527804/
https://www.ncbi.nlm.nih.gov/pubmed/18665168
http://dx.doi.org/10.1038/sj.bjc.6604525

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2527804/
https://www.ncbi.nlm.nih.gov/pubmed/18665168
http://dx.doi.org/10.1038/sj.bjc.6604525

Ejemplares similares